Company / SG&A per Share
Arcutis Biotherapeutics, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.33
FY2025
5-year range
$1.23 / $2.67
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#76 of 210
Health Care
What the data says
At $2.33, Arcutis Biotherapeutics, Inc.'s sg&a per share ranks #135 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 8 years, ranging from $0.60 in FY2020 to $3.59 in FY2019.
Based on SEC 10-K filings.
2.33 in FY2025 with a 5-year CAGR of +31.2%.
Improved from $2.67 to $2.33 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- +31.2%
- 10-Year CAGR
- -
Sector benchmark
#135 of 210 in Health CareTop 64% of 210This company $2.33 Sector average $29.50
▼
-92.1% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 1.7% year-over-year.
- Ranks #76 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.33 | -1.7% |
| FY2024 | $2.37 | -11.3% |
| FY2023 | $2.67 | +20.4% |
| FY2022 | $2.22 | +79.8% |
| FY2021 | $1.23 | +106.3% |
| FY2020 | $0.60 | -83.3% |
| FY2019 | $3.59 | +147.7% |
| FY2018 | $1.45 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026